Breaking News Instant updates and real-time market news.

NNA

Navios Acquisition

$4.09 /

-0.51 (-11.09%)

10:00
12/01/20
12/01
10:00
12/01/20
10:00

Navios Acquisition falls -10.6%

Navios Acquisition is down -10.6%, or -49c to $4.10.

  • 01

    Dec

TODAY'S FREE FLY STORIES

Earnings
Applied Industrial Technologies reports Q2 adjusted EPS 98c, consensus 74c » 06:45
01/28/21
01/28
06:45
01/28/21
06:45
AIT

Applied Industrial Technologies

$76.83 /

-3.09 (-3.87%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIT Applied Industrial Technologies
$76.83 /

-3.09 (-3.87%)

AIT Applied Industrial Technologies
$76.83 /

-3.09 (-3.87%)

11/13/20 KeyBanc
Applied Industrial Technologies price target raised to $85 from $75 at KeyBanc
09/01/20 Sidoti
Applied Industrial Technologies upgraded to Buy from Neutral at Sidoti
08/13/20 Wells Fargo
Applied Industrial Technologies price target raised to $75 from $70 at Wells Fargo
07/02/20 Wells Fargo
Applied Industrial Technologies price target raised to $70 from $60 at Wells Fargo
AIT Applied Industrial Technologies
$76.83 /

-3.09 (-3.87%)

Earnings
MSCI reports Q4 adjusted EPS $1.96, consensus $1.95 » 06:45
01/28/21
01/28
06:45
01/28/21
06:45
MSCI

MSCI

$393.74 /

-10.02 (-2.48%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSCI MSCI
$393.74 /

-10.02 (-2.48%)

MSCI MSCI
$393.74 /

-10.02 (-2.48%)

12/17/20 Barclays
MSCI price target raised to $490 from $360 at Barclays
11/26/20 Atlantic Equities
MSCI downgraded to Neutral from Overweight at Atlantic Equities
10/05/20 Oppenheimer
MSCI initiated with an Outperform at Oppenheimer
10/05/20 Oppenheimer
MSCI initiated with an Outperform at Oppenheimer
MSCI MSCI
$393.74 /

-10.02 (-2.48%)

Recommendations
Lam Research price target raised to $575 from $530 at Mizuho » 06:45
01/28/21
01/28
06:45
01/28/21
06:45
LRCX

Lam Research

$515.47 /

-37.08 (-6.71%)

Mizuho analyst Vijay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LRCX Lam Research
$515.47 /

-37.08 (-6.71%)

LRCX Lam Research
$515.47 /

-37.08 (-6.71%)

01/26/21 Barclays
Lam Research price target raised to $600 from $405 at Barclays
01/25/21 B. Riley Securities
Lam Research price target raised to $650 from $600 at B. Riley Securities
01/25/21 Credit Suisse
Lam Research price target raised to $650 from $450 at Credit Suisse
01/25/21 Deutsche Bank
Lam Research price target raised to $575 from $500 at Deutsche Bank
LRCX Lam Research
$515.47 /

-37.08 (-6.71%)

LRCX Lam Research
$515.47 /

-37.08 (-6.71%)

LRCX Lam Research
$515.47 /

-37.08 (-6.71%)

LRCX Lam Research
$515.47 /

-37.08 (-6.71%)

Downgrade
Morgan Stanley cuts Equitrans Midstream to Underweight on pipeline risk » 06:44
01/28/21
01/28
06:44
01/28/21
06:44
ETRN

Equitrans Midstream

$6.48 /

-0.3 (-4.42%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ETRN Equitrans Midstream
$6.48 /

-0.3 (-4.42%)

ETRN Equitrans Midstream
$6.48 /

-0.3 (-4.42%)

05:31 Today Morgan Stanley
Equitrans downgraded to Underweight from Equal Weight at Morgan Stanley
11/18/20 BofA
Equitrans Midstream upgraded to Neutral from Underperform at BofA
09/25/20 Morgan Stanley
Equitrans Midstream initiated with an Equal Weight at Morgan Stanley
09/09/20 Goldman Sachs
Equitrans Midstream initiated with a Neutral at Goldman Sachs
ETRN Equitrans Midstream
$6.48 /

-0.3 (-4.42%)

Recommendations
Zymeworks price target lowered to $38 from $47 at Barclays » 06:43
01/28/21
01/28
06:43
01/28/21
06:43
ZYME

Zymeworks

$44.12 /

-2.18 (-4.71%)

Barclays analyst Gena…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZYME Zymeworks
$44.12 /

-2.18 (-4.71%)

ZYME Zymeworks
$44.12 /

-2.18 (-4.71%)

01/25/21 Citi
Zymeworks downgraded to Neutral ahead of initial ZW49 data at Citi
01/25/21 Citi
Zymeworks downgraded to Neutral from Buy at Citi
01/12/21 SVB Leerink
Zymeworks price target raised to $66 from $45 at SVB Leerink
01/12/21 Wells Fargo
Zymeworks price target raised to $71 from $58 at Wells Fargo
ZYME Zymeworks
$44.12 /

-2.18 (-4.71%)

Recommendations
j2 Global price target raised to $120 from $98 at JMP Securities » 06:43
01/28/21
01/28
06:43
01/28/21
06:43
JCOM

j2 Global

$106.12 /

+3.68 (+3.59%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JCOM j2 Global
$106.12 /

+3.68 (+3.59%)

JCOM j2 Global
$106.12 /

+3.68 (+3.59%)

12/16/20 JPMorgan
j2 Global price target raised to $120 from $105 at JPMorgan
11/04/20 Baird
j2 Global price target raised to $90 from $85 at Baird
11/04/20 Susquehanna
j2 Global shares remain severely undervalued, says Susquehanna
11/04/20 Citi
j2 Global price target raised to $100 from $90 at Citi
JCOM j2 Global
$106.12 /

+3.68 (+3.59%)

JCOM j2 Global
$106.12 /

+3.68 (+3.59%)

Earnings
Brunswick raises FY21 adjusted EPS view to $6.00-$6.40 from $5.75-$6.25 » 06:42
01/28/21
01/28
06:42
01/28/21
06:42
BC

Brunswick

$91.34 /

-1.26 (-1.36%)

Consensus for FY21 EPS is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BC Brunswick
$91.34 /

-1.26 (-1.36%)

BC Brunswick
$91.34 /

-1.26 (-1.36%)

01/27/21 Truist
Brunswick price target raised to $105 from $95 at Truist
01/12/21 B. Riley Securities
Brunswick price target raised to $102 from $93 at B. Riley Securities
11/20/20 JPMorgan
Brunswick price target raised to $85 from $79 at JPMorgan
10/20/20 JPMorgan
Brunswick upgraded to Overweight on surging boat sales at JPMorgan
BC Brunswick
$91.34 /

-1.26 (-1.36%)

Recommendations
Blackstone price target raised to $75 from $70 at Barclays » 06:42
01/28/21
01/28
06:42
01/28/21
06:42
BX

Blackstone

$65.25 /

+0.13 (+0.20%)

Barclays analyst Jeremy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BX Blackstone
$65.25 /

+0.13 (+0.20%)

BX Blackstone
$65.25 /

+0.13 (+0.20%)

01/27/21 Evercore ISI
Allstate unit sale transaction 'a clear positive,' says Evercore ISI
01/14/21
Fly Intel: Top five analyst initiations
01/14/21 Piper Sandler
Blackstone initiated with an Overweight at Piper Sandler
10/29/20 Oppenheimer
Blackstone upgraded to Outperform at Oppenheimer
BX Blackstone
$65.25 /

+0.13 (+0.20%)

BX Blackstone
$65.25 /

+0.13 (+0.20%)

BX Blackstone
$65.25 /

+0.13 (+0.20%)

BX Blackstone
$65.25 /

+0.13 (+0.20%)

Hot Stocks
Broadridge begins development to be an approved SFT submitter » 06:42
01/28/21
01/28
06:42
01/28/21
06:42
BR

Broadridge

$143.68 /

-8.16 (-5.37%)

Broadridge Financial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BR Broadridge
$143.68 /

-8.16 (-5.37%)

BR Broadridge
$143.68 /

-8.16 (-5.37%)

12/18/20 Truist
Broadridge initiated with a Buy at Truist
12/18/20 Truist
Broadridge initiated with a Buy at Truist
08/17/20 JPMorgan
Broadridge price target raised to $152 from $142 at JPMorgan
08/12/20
Fly Intel: Top five analyst downgrades
BR Broadridge
$143.68 /

-8.16 (-5.37%)

Earnings
Eagle Materials reports Q3 adjusted EPS $1.94, consensus $1.74 » 06:42
01/28/21
01/28
06:42
01/28/21
06:42
EXP

Eagle Materials

$108.24 /

-3.09 (-2.78%)

Reports Q3 revenue $405M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXP Eagle Materials
$108.24 /

-3.09 (-2.78%)

01/22/21 JPMorgan
Eagle Materials price target raised to $130 from $115 at JPMorgan
01/06/21 Loop Capital
Loop raises Eagle Materials price target to $125, names 'best idea' for 2021
11/19/20 Goldman Sachs
Eagle Materials upgraded to Buy from Neutral at Goldman Sachs
11/19/20 Loop Capital
Eagle Materials upgraded to Buy from Hold at Loop Capital
EXP Eagle Materials
$108.24 /

-3.09 (-2.78%)

Recommendations
ServiceNow price target raised to $655 from $650 at Barclays » 06:41
01/28/21
01/28
06:41
01/28/21
06:41
NOW

ServiceNow

$518.15 /

-14.66 (-2.75%)

Barclays analyst Raimo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOW ServiceNow
$518.15 /

-14.66 (-2.75%)

NOW ServiceNow
$518.15 /

-14.66 (-2.75%)

04:58 Today Oppenheimer
ServiceNow price target raised to $610 from $600 at Oppenheimer
01/22/21 OTR Global
ServiceNow upgraded to Positive from Mixed at OTR Global
01/22/21 Cowen
ServiceNow price target raised to $600 from $575 at Cowen
01/21/21 Goldman Sachs
ServiceNow assumed with a Buy at Goldman Sachs
NOW ServiceNow
$518.15 /

-14.66 (-2.75%)

NOW ServiceNow
$518.15 /

-14.66 (-2.75%)

Recommendations
PTC price target raised to $145 from $142 at Barclays » 06:41
01/28/21
01/28
06:41
01/28/21
06:41
PTC

PTC

$121.12 /

-8.44 (-6.51%)

Barclays analyst Saket…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTC PTC
$121.12 /

-8.44 (-6.51%)

PTC PTC
$121.12 /

-8.44 (-6.51%)

06:10 Today RBC Capital
PTC upgraded to Outperform from Sector Perform at RBC Capital
05:29 Today RBC Capital
PTC upgraded to Outperform from Sector Perform at RBC Capital
01/21/21 Barclays
PTC price target raised to $142 from $130 at Barclays
01/12/21 Mizuho
PTC price target raised to $150 from $130 at Mizuho
PTC PTC
$121.12 /

-8.44 (-6.51%)

PTC PTC
$121.12 /

-8.44 (-6.51%)

Hot Stocks
Darling Ingredients, Valero joint venture receives approval for Texas facility » 06:41
01/28/21
01/28
06:41
01/28/21
06:41
DAR

Darling Ingredients

$60.62 /

-5.3 (-8.04%)

, VLO

Valero

$58.76 /

+0.61 (+1.05%)

Darling (DAR) and Valero…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DAR Darling Ingredients
$60.62 /

-5.3 (-8.04%)

VLO Valero
$58.76 /

+0.61 (+1.05%)

DAR Darling Ingredients
$60.62 /

-5.3 (-8.04%)

01/27/21 JPMorgan
Darling Ingredients price target raised to $69 from $48 at JPMorgan
11/05/20 BMO Capital
Darling Ingredients price target raised to $46 from $33 at BMO Capital
10/22/20 Roth Capital
Darling Ingredients price target raised to $84 from $38 at Roth Capital
10/21/20 Wolfe Research
Darling Ingredients initiated with an Outperform at Wolfe Research
VLO Valero
$58.76 /

+0.61 (+1.05%)

01/26/21
Fly Intel: Top five analyst initiations
01/26/21
Valero started with a Neutral at UBS on 'valuation near historic levels'
01/26/21 UBS
Valero initiated with a Neutral at UBS
12/11/20 Morgan Stanley
Morgan Stanley upgrades two, downgrades one in refining rating rebalance
DAR Darling Ingredients
$60.62 /

-5.3 (-8.04%)

VLO Valero
$58.76 /

+0.61 (+1.05%)

VLO Valero
$58.76 /

+0.61 (+1.05%)

VLO Valero
$58.76 /

+0.61 (+1.05%)

VLO Valero
$58.76 /

+0.61 (+1.05%)

Recommendations
Navient price target raised to $16 from $13 at Barclays » 06:40
01/28/21
01/28
06:40
01/28/21
06:40
NAVI

Navient

$11.16 /

-0.71 (-5.98%)

Barclays analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NAVI Navient
$11.16 /

-0.71 (-5.98%)

NAVI Navient
$11.16 /

-0.71 (-5.98%)

01/19/21 JPMorgan
Navient downgraded to Neutral with $12.50 target at JPMorgan
01/19/21 JPMorgan
Navient downgraded to Neutral from Overweight at JPMorgan
10/22/20
Fly Intel: Top five analyst upgrades
10/22/20 Wedbush
Navient upgraded to Outperform at Wedbush
NAVI Navient
$11.16 /

-0.71 (-5.98%)

NAVI Navient
$11.16 /

-0.71 (-5.98%)

Hot Stocks
Jackson to fully separate from Prudential through proposed spin-off in Q2 » 06:40
01/28/21
01/28
06:40
01/28/21
06:40
PRU

Prudential

$79.19 /

-2.02 (-2.49%)

, MET

MetLife

$48.41 /

-1.69 (-3.37%)

Prudential (PRU), the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRU Prudential
$79.19 /

-2.02 (-2.49%)

MET MetLife
$48.41 /

-1.69 (-3.37%)

PRU Prudential
$79.19 /

-2.02 (-2.49%)

12/08/20 Citi
Prudential upgraded to Neutral from Sell at Citi
12/04/20 Goldman Sachs
Prudential initiated with a Buy at Goldman Sachs
11/17/20 Barclays
Prudential initiated with an Equal Weight at Barclays
05/06/20 Piper Sandler
Prudential downgraded to Neutral at Piper Sandler following Q1 results
MET MetLife
$48.41 /

-1.69 (-3.37%)

01/06/21
Fly Intel: Top five analyst upgrades
01/06/21 Piper Sandler
MetLife upgraded to Overweight from Neutral at Piper Sandler
12/08/20 Citi
MetLife upgraded to Buy from Neutral at Citi
12/04/20 Goldman Sachs
MetLife initiated with a Neutral at Goldman Sachs
PRU Prudential
$79.19 /

-2.02 (-2.49%)

MET MetLife
$48.41 /

-1.69 (-3.37%)

MET MetLife
$48.41 /

-1.69 (-3.37%)

PRU Prudential
$79.19 /

-2.02 (-2.49%)

MET MetLife
$48.41 /

-1.69 (-3.37%)

MET MetLife
$48.41 /

-1.69 (-3.37%)

Initiation
SOC Telemed initiated with an Outperform at RBC Capital » 06:39
01/28/21
01/28
06:39
01/28/21
06:39
TLMD

SOC Telemed

/

+

RBC Capital analyst Sean…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TLMD SOC Telemed
/

+

TLMD SOC Telemed
/

+

01/15/21 Benchmark
SOC Telemed initiated with a Buy at Benchmark
01/15/21 BTIG
SOC Telemed downgraded to Neutral from Buy at BTIG
01/15/21 BTIG
SOC Telemed downgraded to Neutral from Buy at BTIG
01/08/21 Baird
Vocera downgraded to Neutral on valuation at Baird
TLMD SOC Telemed
/

+

Hot Stocks
Eli Lilly to acquire exclusive rights for AK1780 from Asahi Kasei Pharm » 06:39
01/28/21
01/28
06:39
01/28/21
06:39
LLY

Eli Lilly

$207.73 /

-5.17 (-2.43%)

Eli Lilly and Company and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$207.73 /

-5.17 (-2.43%)

LLY Eli Lilly
$207.73 /

-5.17 (-2.43%)

01/27/21 H.C. Wainwright
Vir collaboration gives H.C. Wainwright more confidence in COVID-19 program
01/26/21 Berenberg
Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg
01/20/21 Citi
Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data
01/19/21 Roth Capital
Merus price target raised to $32 from $19 at Roth Capital
LLY Eli Lilly
$207.73 /

-5.17 (-2.43%)

LLY Eli Lilly
$207.73 /

-5.17 (-2.43%)

LLY Eli Lilly
$207.73 /

-5.17 (-2.43%)

LLY Eli Lilly
$207.73 /

-5.17 (-2.43%)

Earnings
Brunswick reports Q4 adjusted EPS $1.32, consensus $1.02 » 06:39
01/28/21
01/28
06:39
01/28/21
06:39
BC

Brunswick

$91.34 /

-1.26 (-1.36%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BC Brunswick
$91.34 /

-1.26 (-1.36%)

BC Brunswick
$91.34 /

-1.26 (-1.36%)

01/27/21 Truist
Brunswick price target raised to $105 from $95 at Truist
01/12/21 B. Riley Securities
Brunswick price target raised to $102 from $93 at B. Riley Securities
11/20/20 JPMorgan
Brunswick price target raised to $85 from $79 at JPMorgan
10/20/20 JPMorgan
Brunswick upgraded to Overweight on surging boat sales at JPMorgan
BC Brunswick
$91.34 /

-1.26 (-1.36%)

Recommendations
Duke Energy price target raised to $108 from $102 at Barclays » 06:38
01/28/21
01/28
06:38
01/28/21
06:38
DUK

Duke Energy

/

+

Barclays analyst Eric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DUK Duke Energy
/

+

DUK Duke Energy
/

+

01/14/21 Goldman Sachs
Duke Energy downgraded to Neutral from Buy at Goldman Sachs
11/24/20
Fly Intel: Top five analyst initiations
11/24/20 BMO Capital
Duke Energy initiated with an Outperform at BMO Capital
11/18/20 Barclays
Duke Energy price target raised to $102 from $87 at Barclays
DUK Duke Energy
/

+

DUK Duke Energy
/

+

DUK Duke Energy
/

+

DUK Duke Energy
/

+

Recommendations
General Electric price target raised to $13 from $12 at Barclays » 06:38
01/28/21
01/28
06:38
01/28/21
06:38
GE

General Electric

/

+

Barclays analyst Julian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GE General Electric
/

+

GE General Electric
/

+

01/27/21 Morgan Stanley
General Electric price target raised to $13 from $12 at Morgan Stanley
01/27/21 Citi
General Electric developing track record of delivering, says Citi
01/07/21 JPMorgan
GE shares 'de-coupled from long term fundamentals,' says JPMorgan
12/16/20 DZ Bank
General Electric upgraded to Hold from Sell at DZ Bank
GE General Electric
/

+

GE General Electric
/

+

GE General Electric
/

+

GE General Electric
/

+

Recommendations
Nasdaq price target raised to $160 from $155 at Barclays » 06:38
01/28/21
01/28
06:38
01/28/21
06:38
NDAQ

Nasdaq

$141.42 /

+0.25 (+0.18%)

Barclays analyst Jeremy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NDAQ Nasdaq
$141.42 /

+0.25 (+0.18%)

NDAQ Nasdaq
$141.42 /

+0.25 (+0.18%)

01/19/21
Nasdaq upgraded to Buy at UBS on robust volume and organic growth trends
01/19/21 UBS
Nasdaq upgraded to Buy from Neutral at UBS
01/13/21 Deutsche Bank
Nasdaq price target raised to $163 from $159 at Deutsche Bank
01/12/21 Barclays
Nasdaq price target raised to $155 from $147 at Barclays
NDAQ Nasdaq
$141.42 /

+0.25 (+0.18%)

NDAQ Nasdaq
$141.42 /

+0.25 (+0.18%)

NDAQ Nasdaq
$141.42 /

+0.25 (+0.18%)

NDAQ Nasdaq
$141.42 /

+0.25 (+0.18%)

Earnings
McCormick sees FY21 adjusted EPS $2.91-$2.96, consensus $2.96 » 06:38
01/28/21
01/28
06:38
01/28/21
06:38
MKC

McCormick

$94.08 /

-2.01 (-2.09%)

Sees FY21 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MKC McCormick
$94.08 /

-2.01 (-2.09%)

MKC McCormick
$94.08 /

-2.01 (-2.09%)

11/24/20 Stifel
Stifel sees McCormick's acquisition of Cholula brand as 'strategic'
09/24/20 Argus
McCormick initiated with a Buy at Argus
07/15/20 Credit Suisse
McCormick price target raised to $200 from $187 at Credit Suisse
06/26/20 Deutsche Bank
McCormick price target raised to $182 from $156 at Deutsche Bank
MKC McCormick
$94.08 /

-2.01 (-2.09%)

MKC McCormick
$94.08 /

-2.01 (-2.09%)

MKC McCormick
$94.08 /

-2.01 (-2.09%)

Hot Stocks
Northrop Grumman sees FY21 adjusted free cash flow ~$3B-$3.3B » 06:38
01/28/21
01/28
06:38
01/28/21
06:38
NOC

Northrop Grumman

$292.98 /

-0.03 (-0.01%)

Sees FY21 operating cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

01/07/21 Baird
Northrop Grumman downgraded to Neutral from Outperform at Baird
12/09/20 Noble Capital
Kratos Defense price target raised to $26 from $23 at Noble Capital
11/03/20 Morgan Stanley
Morgan Stanley sees attractive buying opportunity in Defense stocks
10/13/20 Credit Suisse
Northrop Grumman price target lowered to $390 from $400 at Credit Suisse
NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

Hot Stocks
Northrop Grumman reports backlog of $81B  06:36
01/28/21
01/28
06:36
01/28/21
06:36
NOC

Northrop Grumman

$292.98 /

-0.03 (-0.01%)

 
ShowHide Related Items >><<
NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

01/07/21 Baird
Northrop Grumman downgraded to Neutral from Outperform at Baird
12/09/20 Noble Capital
Kratos Defense price target raised to $26 from $23 at Noble Capital
11/03/20 Morgan Stanley
Morgan Stanley sees attractive buying opportunity in Defense stocks
10/13/20 Credit Suisse
Northrop Grumman price target lowered to $390 from $400 at Credit Suisse
NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

Earnings
Northrop Grumman sees FY21 adjusted EPS $23.15-$23.65, consensus $24.19 » 06:36
01/28/21
01/28
06:36
01/28/21
06:36
NOC

Northrop Grumman

$292.98 /

-0.03 (-0.01%)

Lowers FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

01/07/21 Baird
Northrop Grumman downgraded to Neutral from Outperform at Baird
12/09/20 Noble Capital
Kratos Defense price target raised to $26 from $23 at Noble Capital
11/03/20 Morgan Stanley
Morgan Stanley sees attractive buying opportunity in Defense stocks
10/13/20 Credit Suisse
Northrop Grumman price target lowered to $390 from $400 at Credit Suisse
NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

NOC Northrop Grumman
$292.98 /

-0.03 (-0.01%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.